Clinical significance of early-onset hyperuricemia in renal transplant recipients

Nephron - Clinical Practice

Volumn 117, Issue 3, 2011, Pages

  Chung, Byung Ha ^a,b   Kang, Seok Hui ^a,b   Hwang, Hyeon Seok ^a,b   Choi, Bum Soon ^a,b   Park, Cheol Whee ^a,b   Kim, Yong Soo ^a,b   Kim, Ji Il ^a,c   Moon, In Sung ^a,c   Yang, Chul Woo ^a,b,c  

^a Transplant Research Center   (South Korea)

^b Division of Nephrology   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Allograft dysfunction; Kidney transplantation; Uric acid

Indexed keywords

CREATININE; URIC ACID;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HYPERURICEMIA; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; URIC ACID BLOOD LEVEL;

ADULT; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; HYPERURICEMIA; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; URIC ACID;

EID: 77956601977     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320743     Document Type: Article

References (24)

1. Lehto S, Niskanen L, Rönnemaa T, Laakso M: Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 1998;29:635-639. (Pubitemid 28145791)
2. Iseki K, Oshiro S, Tozawa M, Iseki C, Ikemiya Y, Takishita S: Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res 2001;24:691-697. (Pubitemid 33133783)
3. Kang D, Nakagawa T: Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease. Semin Nephrol 2005;25:43-49. (Pubitemid 40128148)
4. Ohno I, Hosoya T, Gomi H, Ichida K, Okabe H, Hikita M: Serum uric acid and renal prognosis in patients with IgA nephropathy. Nephron 2001;87:333-339. (Pubitemid 32260834)
5. Johnson RJ, Kivlighn SD, Kim YG, Suga S, Fogo AB: Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease. Am J Kidney Dis 1999;33:225-234. (Pubitemid 29072223)
6. Bandukwala F, Huang M, Zaltzman JS, Nash M, Prasad GV: Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk. Am J Cardiol 2009;103:867-871.
7. Akalin E, Ganeshan SV, Winston J, Muntner P: Hyperuricemia is associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathy. Transplantation 2008;86:652-658.
8. Armstrong KA, Johnson DW, Campbell SB, Isbel NM, Hawley CM: Does uric acid have a pathogenetic role in graft dysfunction and hypertension in renal transplant recipients? Transplantation 2005;80:1565-1571. (Pubitemid 43005867)
9. Clive DM: Renal transplant-associated hyperuricemia and gout. J Am Soc Nephrol 2000;11:974-979. (Pubitemid 30241734)
10. Akgul A, Bilgic A, Ibis A, Ozdemir FN, Arat Z, Haberal M: Is uric acid a predictive factor for graft dysfunction in renal transplant recipients? Transplant Proc 2007;39:1023-1026. (Pubitemid 46764870)
11. Karthikeyan V, Karpinski J, Nair RC, Knoll G: The burden of chronic kidney disease in renal transplant recipients. Am J Transplant 2004;4:262-269. (Pubitemid 38248531)
12. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470. (Pubitemid 29135798)
13. Min SI, Yun IJ, Kang JM, Park YJ, Min SK, Ahn C, Kim SJ, Ha J: Moderate-to-severe early-onset hyperuricaemia: a prognostic marker of long-term kidney transplant outcome. Nephrol Dial Transplant 2009;24:2584-2590.
14. Kanbay M, Akcay A, Huddam B, Usluogullari CA, Arat Z, Ozdemir FN, Haberal M: Influence of cyclosporine and tacrolimus on serum uric acid levels in stable kidney transplant recipients. Transplantation Proc 2005;37:3119-3120. (Pubitemid 41435638)
15. Costa de Oliveira CM, Mota MU, Mota RS, Nóbrega JO, Melo DS, Vieira AS, Fernandes PF, Campos Hde H, Evangelista JB Jr: Prevalence and staging of chronic kidney disease in renal transplant recipients. Clin Transplant 2009;23:628-636.
16. Marcén R, Pascual J, Tenorio M, Ocaña EJ, Teruel JL, Villafruela JJ, Fernández M, Burgos FJ, Ortuño J: Chronic kidney disease in renal transplant recipients. Transplant Proc 2005;37:3718-3720. (Pubitemid 43015144)
17. Hariharan S, McBride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson CP: Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002;62:311-318. (Pubitemid 34754077)
18. Navaneethan SD, Beddhu S: Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease. Nephrol Dial Transplant 2009;24:1260-1266.
19. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ: Hyperuricemia induces endothelial dysfunction. Kidney Int 2005;67:1739-1742. (Pubitemid 40577708)
20. Kato M, Hisatome I, Tomikura Y, Kotani K, Kinugawa T, Ogino K, Ishida K, Igawa O, Shigemasa C, Somers VK: Status of endothelial dependent vasodilation in patients with hyperuricemia. Am J Cardiol 2005;96:1576-1578. (Pubitemid 41690182)
21. Ruggiero C, Cherubini A, Ble A, Bos AJ, Maggio M, Dixit VD, Lauretani F, Bandinelli S, Senin U, Ferrucci L: Uric acid and inflammatory markers. Eur Heart J 2006;27:1174-1181.
22. Kang D, Park S, Lee I, Johnson RJ: Uric acidinduced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005;16:3553-3562. (Pubitemid 46211276)
23. LaSpina M, Tripathi S, Gatto LA, Bruch D, Maier KG, Kittur DS: An interleukin-6-neutralizing antibody prevents cyclosporine-induced nephrotoxicity in mice. J Surg Res 2008;148:121-125.
24. Li C, Sun BK, Lim SW, Song JC, Kang S, Kim YS, Kang DH, Cha JH, Kim J, Yang CW: Combined effects of losartan and pravastatin on interstitial inflammation and fibrosis in chronic cyclosporine-induced nephropathy. Transplantation 2005;79:1522-1529. (Pubitemid 40847583)